Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

An Alternative Approach for Improved Entrapment Efficiency of Hydrophilic Drug Substance in PLGA Nanoparticles by Interfacial Polymer Deposition Following Solvent Displacement

Sara Salatin 1 , 2 , Jaleh Barar 1 , 3 , Mohammad Barzegar-Jalali 3 , Khosro Adibkia 3 , 4 , Farhad Kiafar 3 , 5 and Mitra Jelvehgari 3 , 4 , *
Authors Information
1 Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
2 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
4 Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
5 Zahravi Pharmaceutical Company, Tabriz, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: 13 (4); e12873
  • Published Online: December 2, 2018
  • Article Type: Research Article
  • Received: August 26, 2016
  • Revised: December 12, 2017
  • Accepted: January 7, 2018
  • DOI: 10.5812/jjnpp.12873

To Cite: Salatin S, Barar J, Barzegar-Jalali M , Adibkia K, Kiafar F, et al. An Alternative Approach for Improved Entrapment Efficiency of Hydrophilic Drug Substance in PLGA Nanoparticles by Interfacial Polymer Deposition Following Solvent Displacement, Jundishapur J Nat Pharm Prod. Online ahead of Print ; 13(4):e12873. doi: 10.5812/jjnpp.12873.

Abstract
Copyright © 2018, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Di Stefano A, Iannitelli A, Laserra S, Sozio P. Drug delivery strategies for Alzheimer's disease treatment. Expert Opin Drug Deliv. 2011;8(5):581-603. doi: 10.1517/17425247.2011.561311. [PubMed: 21391862].
  • 2. Jain KK. Nanobiotechnology-based strategies for crossing the blood-brain barrier. Nanomedicine (Lond). 2012;7(8):1225-33. doi: 10.2217/nnm.12.86. [PubMed: 22931448].
  • 3. Salatin S, Maleki Dizaj S, Yari Khosroushahi A. Effect of the surface modification, size, and shape on cellular uptake of nanoparticles. Cell Biol Int. 2015;39(8):881-90. doi: 10.1002/cbin.10459. [PubMed: 25790433].
  • 4. Dizaj SM, Vazifehasl Z, Salatin S, Adibkia K, Javadzadeh Y. Nanosizing of drugs: Effect on dissolution rate. Res Pharm Sci. 2015;10(2):95-108. [PubMed: 26487886]. [PubMed Central: PMC4584458].
  • 5. Salatin S, Jelvehgari M, Maleki-Dizaj S, Adibkia K. A sight on protein-based nanoparticles as drug/gene delivery systems. Ther Deliv. 2015;6(8):1017-29. doi: 10.4155/tde.15.28. [PubMed: 26305428].
  • 6. Tosi G, Bortot B, Ruozi B, Dolcetta D, Vandelli MA, Forni F, et al. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. Curr Med Chem. 2013;20(17):2212-25. doi: 10.2174/0929867311320170006. [PubMed: 23458620].
  • 7. Fessi HPFD, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 1989;55(1):R1-4. doi: 10.1016/0378-5173(89)90281-0.
  • 8. Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm. 1998;24(12):1113-28. doi: 10.3109/03639049809108571. [PubMed: 9876569].
  • 9. Sharma D, Maheshwari D, Philip G, Rana R, Bhatia S, Singh M, et al. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: In vitro and in vivo evaluation. Biomed Res Int. 2014;2014:156010. doi: 10.1155/2014/156010. [PubMed: 25126544]. [PubMed Central: PMC4122152].
  • 10. Loveymi BD, Jelvehgari M, Zakeri-Milani P, Valizadeh H. Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability. Adv Pharm Bull. 2012;2(1):43-56. doi: 10.5681/apb.2012.007. [PubMed: 24312770]. [PubMed Central: PMC3846008].
  • 11. Benkic P, Smrkolj M, Pecavar A, Stropnik T, Vrbinc M, Vrecer F, et al. Amorphous and crystalline forms of rivastigmine hydrogen tartrate. Eur Pat Applic. 2008:1-30.
  • 12. Liu J, Qiu Z, Wang S, Zhou L, Zhang S. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity. Biomed Mater. 2010;5(6):65002. doi: 10.1088/1748-6041/5/6/065002. [PubMed: 20924138].
  • 13. Derman S. Caffeic acid phenethyl ester loaded PLGA nanoparticles: effect of various process parameters on reaction yield, encapsulation efficiency, and particle size. J Nanomaterials. 2015;16(1):318. doi: 10.1080/10915810802244595.
  • 14. Domanska U, Halayqa M. Promazine Hydrochloride/PLGA biodegradable nanoparticles formulation and release. J Phys Chem Biophys. 2014;4(2):1000143. doi: 10.4172/2161-0398.1000143.
  • 15. Tefas LR, Tomuta I, Achim M, Vlase L. Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. Clujul Med. 2015;88(2):214-23. doi: 10.15386/cjmed-418. [PubMed: 26528074]. [PubMed Central: PMC4576773].
  • 16. Salatin S, Barar J, Barzegar-Jalali M, Adibkia K, Kiafar F, Jelvehgari M. Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles. Res Pharm Sci. 2017;12(1):1. doi: 10.4103/1735-5362.199041. [PubMed: 28255308]. [PubMed Central: PMC5333474].
  • 17. Amaro MI, Simon A, Cabral LM, de Sousa VP, Healy AM. Rivastigmine hydrogen tartrate polymorphs: Solid-state characterisation of transition and polymorphic conversion via milling. Solid State Sci. 2015;49:29-36. doi: 10.1016/j.solidstatesciences.2015.09.004.
  • 18. Graeser KA, Strachan CJ, Patterson JE, Gordon KC, Rades T. Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin. Crystal Growth Design. 2008;8(1):128-35. doi: 10.1021/cg700913m.
  • 19. Joshi SA, Chavhan SS, Sawant KK. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur J Pharm Biopharm. 2010;76(2):189-99. doi: 10.1016/j.ejpb.2010.07.007. [PubMed: 20637869].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments